|
Delayed
Australian S.E.
21:04:11 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.4800 AUD | 0.00% |
|
-1.03% | -51.02% |
| 09-01 | Cyclopharm Limited, H1 2026 Earnings Call, Sep 02, 2026 | |
| 08-24 | Cyclopharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Evolution of the Average Target: Cyclopharm Limited
Evolution of the Target Price: Cyclopharm Limited
Changes in Analyst Recommendations: Cyclopharm Limited
ca1bf9e7c0fdf8245fb0f6ee1e2e807a.f6o1B_TICaU-tHV8HG-JBLMFGdrDZuFIRS3LQfGJUSo.TetbXra9Q-Nt3QwQUAD4PNZDQ--VMtQ8DUyFBa7lIGEg_UFynolw1k71Eg~8cc658a52397e849a19affdc8bd75418
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +101.08% | |||
| +0.59% | |||||
| +9.42% | |||||
| +26.3% | |||||
| +41.33% | |||||
| +17.11% | |||||
| +17.75% | |||||
| +16.43% | |||||
| +6.14% | |||||
| +7.41% | |||||
| Average | +24.35% | |||||
| Weighted average by Cap. | +13.28% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3424USD
Average target price
0.7170USD
Spread / Average Target
+109.42%
High Price Target
0.7170USD
Spread / Highest target
+109.42%
Low Price Target
0.7170USD
Spread / Lowest Target
+109.42%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- CYC Stock
- Consensus Cyclopharm Limited
Select your edition
All financial news and data tailored to specific country editions
